Sugita K - Search Results

1

Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.

Takeda Y, Kasai H, Uchida N, Yoshida H, Maekawa R, Sugita K, Yoshioka T. Takeda Y, et al. Among authors: sugita k. Anticancer Res. 1999 Sep-Oct;19(5B):4059-64. Anticancer Res. 1999. PMID: 10628354

2

Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA.

Tanaka H, Hojo K, Yoshida H, Yoshioka T, Sugita K. Tanaka H, et al. Among authors: sugita k. Biochem Biophys Res Commun. 1993 Feb 15;190(3):732-40. doi: 10.1006/bbrc.1993.1110. Biochem Biophys Res Commun. 1993. PMID: 8382489

3

[Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide].

Uchida N, Kasai H, Takeda Y, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Gan To Kagaku Ryoho. 1998 Jan;25(1):79-87. Gan To Kagaku Ryoho. 1998. PMID: 9464333 Japanese.

4

Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.

Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M. Tamura Y, et al. Among authors: sugita k. J Med Chem. 1998 Feb 12;41(4):640-9. doi: 10.1021/jm9707582. J Med Chem. 1998. PMID: 9484512

5

Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.

Uchida N, Kasai H, Takeda Y, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Anticancer Res. 1998 Jan-Feb;18(1A):247-52. Anticancer Res. 1998. PMID: 9568085

6

Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase.

Yoshioka T, Wada T, Uchida N, Maki H, Yoshida H, Ide N, Kasai H, Hojo K, Shono K, Maekawa R, Yagi S, Hoffman RM, Sugita K. Yoshioka T, et al. Among authors: sugita k. Cancer Res. 1998 Jun 15;58(12):2583-7. Cancer Res. 1998. PMID: 9635582

7

Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor model.

Uchida N, Takeda Y, Kasai H, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Anticancer Res. 1998 Sep-Oct;18(5A):3375-9. Anticancer Res. 1998. PMID: 9858911

8

[Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].

Uchida N, Takeda Y, Kasai H, Hojo K, Wada T, Nishida K, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Gan To Kagaku Ryoho. 1998 Dec;25(14):2267-74. Gan To Kagaku Ryoho. 1998. PMID: 9881084 Japanese.

9

Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model.

Uchida N, Takeda Y, Hojo K, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Eur J Cancer. 1998 Oct;34(11):1796-801. doi: 10.1016/s0959-8049(98)00194-4. Eur J Cancer. 1998. PMID: 9893671

10

Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor.

Maekawa R, Maki H, Yoshida H, Hojo K, Tanaka H, Wada T, Uchida N, Takeda Y, Kasai H, Okamoto H, Tsuzuki H, Kambayashi Y, Watanabe F, Kawada K, Toda K, Ohtani M, Sugita K, Yoshioka T. Maekawa R, et al. Among authors: sugita k. Cancer Res. 1999 Mar 15;59(6):1231-5. Cancer Res. 1999. PMID: 10096553

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results